Autologous Graft versus Host Disease: An Emerging Complication in Patients with Multiple Myeloma

Figure 1

Immune parameters of HPC products among the healthy control group, the group of MM patients who developed autoGVHD, and the group of MM patients who did not develop autoGVHD. Mean percentages of lymphocytes are shown for CD3⁺, CD4⁺, CD8⁺, and NK (CD3⁻CD56⁺). Mean percentages of CD4-positive T-cells that are FoxP3⁺/CD25⁺ are shown for Tregs. The bars represent standard error of means.

(a)

(b)

(c)

(d)

(e)